InvestorsObserver is giving GT Biopharma Inc (GTBP) an Analyst Rating Rank of 75, meaning GTBP is ranked higher by analysts than 75% of stocks. The average price target for GTBP is $25.333 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating GTBP a Strong Buy today. Find out what this means to you and get the rest of the rankings on GTBP!